Article · 27 Dec 2024
Conference abstractPublished 11 Sep 2017
Predicting placebo and subpopulation effects with NetraAI’s machine learning technology
NetraMark Corp, Canada
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pharmaceutical companies are using machine-learning (ML) algorithms to help them deal with difficult clinical trials. There are however two inherent problems that pharmaceutical companies face when attempting this type of remedy: 1) Complex patient population heterogeneity and 2) Relatively small sample sizes. The first issue provides a difficult setting for ML methods simply because many algorithms are going to try to do their best to learn what is asked of them, e.g., responders vs. nonresponders as labeled by a clinician, which may be inaccurate. Further, the variables collected may actually have nothing to do with why a subset of patients respond, and so the machine ends up providing models based on data artifacts. This destroys vital predictability. The second issue is well known but we have discovered that by utilizing geometry to extract several perspectives of high dimensional data in a simple to read way, the machine can learn and extrapolate in an accurate way. The NetraAI system is thus capable of identifying those subjects who are predictable from the data that is provided and in addition, capable of quickly learning about the patient population so that predictions for placebo, safety, and efficacy can be trusted. We will provide examples derived from academic and pharmaceutical data sets.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 23 Dec 2024
The Use of AI and Machine Learning in Predicting Drug-Drug Interactions
Article · 28 Oct 2024
Advances in Computational Drug Design: Machine Learning Techniques for Predicting Drug-Target Interactions
Perspective · 25 Sep 2024
Artificial Intelligence in Predictive Toxicology: Enhancing Drug Safety Assessments through Machine Learning
Article · 26 Jul 2024
Utilizing Machine Learning for Predictive Toxicology in Drug Development
More from this journal
The newest in Journal of Clinical Trials.
Case report · 10 Aug 2026
Tuberculosis Associated Spondylolisthesis and Radiculopathy
Short communication · 31 Jul 2026
Understanding Bioavailability as a Key Element in Effective Therapeutic Delivery
Research article · 14 Jun 2026
Ensuring Rights and Dignity in Ethical Practices of Clinical Studies with Vulnerable Group and Safeguarding Vulnerable Group Act (2006)
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Trials
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Joseph Geraci”

